Elevation of Fasting GLP-1 Levels in Child and Adolescent Obesity: Friend or Foe?

Glucagon-like peptide-1 (GLP-1) receptor agonists have been gaining much attention as a therapeutic approach to type 2 diabetes and obesity. Stinson et al recently reported that fasting GLP-1 is higher in children and adolescents with overweight/obesity and that it associates with cardiometabolic ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Sodai, Yabe, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372656/
https://www.ncbi.nlm.nih.gov/pubmed/33950185
http://dx.doi.org/10.1210/clinem/dgab301